Solvay Ventures, Solvay's venture capital arm, manages a $100M evergreen fund.
Location
City of Brussels, Brussels-Capital Region, BE
Founded
2016
Solvay Ventures, the venture capital arm of Solvay, manages a $100 million evergreen fund focused on investing in innovative solutions that address complex challenges through scientific research and technology. The firm typically participates in various investment stages, including Seed, Series A, Series B, and Series C rounds, with a notable presence in Series A and Series B investments.
Notable portfolio companies include Autonomic Materials, Compact Membrane Systems, DMC Biotechnologies, Phase Two Chemicals, and Zeda. Solvay Ventures is led by a team committed to transforming scientific research into industrial applications through open innovation and bold collaborations. The firm offers unique value-add services by leveraging its extensive industry expertise and network to support the growth and success of its portfolio companies.
Solvay Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages